Trade Summary

1 week ago, Morris Arlene, serving as Dir at Cogent Biosciences, Inc. (COGT), sold 45,510 shares at $37.12 per share, for a total transaction value of $1,689,492.96.

This sale represents a 100.00% decrease in Morris Arlene's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 27, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 31, 2026 at 5:01 PM ET, 4 days after the trade was made.

Cogent Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.